GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population. - Wikidata - wikimedia - TriplyDB

GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population.

GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population.

http://www.wikidata.org/entity/Q43239477

about

Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers Glutathione S-transferase M1 gene polymorphism and laryngeal cancer risk: a meta-analysis.Association between GSTM1 and GSTT1 allelic variants and head and neck squamous cell cancinoma.GSTM1 null genotype is a risk factor for laryngeal cancer.Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis.GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis.Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.GSTM3 reverses the resistance of hepatoma cells to radiation by regulating the expression of cell cycle/apoptosis-related molecules.N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case-control studies.GSTM1 null polymorphisms is associated with laryngeal cancer risk: a meta-analysis.CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma.

P2860

Q27010137-69222FBE-54B6-4E1C-8B3C-B48937C0F318 Q34382630-9F7F7053-073C-49B8-9156-EE137D6BC3B6 Q34450974-105615D2-4F23-418C-8767-ABAB7075FF58 Q35870870-D4839CD6-5C19-4AED-8A7B-BAA109077519 Q35995433-80995AA9-6FCF-4649-B9BB-BF40E896FA11 Q37452500-BC56A849-E973-4C11-A254-3FF865CECF70 Q37696716-DC56EECC-6490-4665-9196-52570DD5034E Q38421437-6788F850-D493-4A59-A61E-3B4768AE032F Q38958277-5450A749-6D00-475F-87D1-67DCF88943D4 Q44997557-7C357E48-08CB-4BAF-8CDF-30FF2DC2F33A Q46826082-F9656DD0-F4BA-46BD-9691-7289BBC2ABB6 Q54352095-924B9A56-0455-4BDD-8DFF-B230A60F624E

P2860

GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population.

http://www.wikidata.org/entity/Q43239477

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

GSTT1, GSTM1, GSTM3 and NAT2 p ...... rcinoma in a Greek population.

@en

GSTT1, GSTM1, GSTM3 and NAT2 p ...... rcinoma in a Greek population.

@nl

type

label

GSTT1, GSTM1, GSTM3 and NAT2 p ...... rcinoma in a Greek population.

@en

GSTT1, GSTM1, GSTM3 and NAT2 p ...... rcinoma in a Greek population.

@nl

prefLabel

GSTT1, GSTM1, GSTM3 and NAT2 p ...... rcinoma in a Greek population.

@en

GSTT1, GSTM1, GSTM3 and NAT2 p ...... rcinoma in a Greek population.

@nl

P1433

Q43239477-DDACE36B-D243-432A-ACF0-10EC45C1CF01

P1476

Q43239477-89F7267E-5866-45D8-AD94-54F2B3F444E2

P2093

Q43239477-0C8FCC0C-840D-477C-A86A-7CD54454898A

Q43239477-349BF694-4E15-4F2E-A618-A3315D978A24

Q43239477-7356E0DF-FFAB-493C-9511-02B27EA800AE

Q43239477-763D756A-29E4-40F5-8EE2-302E7647AEA3

Q43239477-BD79AABD-7E9A-46F2-A91D-131A2FBADDAC

Q43239477-BDDD3A78-BFAE-4D3D-9E32-DEFF1E6198E3

P2860

Q43239477-0783567F-F488-465A-9F75-049015805C94

Q43239477-0C5223E8-C9CA-4242-B106-8D64F7526C7F

Q43239477-217D95D3-1F38-4D98-8A14-7C6463930E38

Q43239477-248D265D-19A7-4F9F-99F4-B2456B542234

Q43239477-511E8300-28C6-469C-8123-E250B34A177D

Q43239477-910250FB-3118-403B-A8C1-7C174496B49D

Q43239477-9A000338-E339-493A-BFA9-9B927A9C39CD

Q43239477-A9F2ED56-FC9F-4A8D-A367-5A11A39E51F8

Q43239477-E8669FDA-D170-4100-9021-F699DF7E0733

P304

Q43239477-2005363E-1545-4A65-8D12-0F94D62A9103

P31

Q43239477-DB3618ED-982F-44F9-88A3-2FC632328B17

P356

Q43239477-18EE8BE2-7B83-480C-AFC8-33CC2C525B2A

P433

Q43239477-59EC5BFD-976A-418F-8CE4-1873AAAD1ADE

P478

Q43239477-2DC77F61-9E3C-4107-AED6-716C8E65AF46

P50

Q43239477-BF07A29B-0D12-4C6D-BB15-4C76BDE60D91

P577

Q43239477-4832959D-681D-4DF6-8900-AC77FFE8915C

P698

Q43239477-5EDC9B2E-50F0-4AC5-B530-9D0CC640128A

P356

S002221510999154X

P1433

The Journal of Laryngology & Otology

P1476

GSTT1, GSTM1, GSTM3 and NAT2 p ...... rcinoma in a Greek population.

@en

P2093

A Tzagaroulakis

http://www.w3.org/2001/XMLSchema#string

J Xenellis

http://www.w3.org/2001/XMLSchema#string

K Banis

http://www.w3.org/2001/XMLSchema#string

M Chatzimichalis

http://www.w3.org/2001/XMLSchema#string

M Gazouli

http://www.w3.org/2001/XMLSchema#string

P Sarof

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetics of the arylamine N-acetyltransferases.

Molecular mechanism of slow acetylation of drugs and carcinogens in humans.

Molecular mechanisms of genetic polymorphisms of drug metabolism.

Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A.

Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.

Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans.

CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.

Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.

Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans.

P304

318-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S002221510999154X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Athanasios Bibas

P577

2009-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19922706

http://www.w3.org/2001/XMLSchema#string